PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway
Publisher: Spandidos Publications
ISSN: 1021-335X
Source: Oncology Reports, Vol.28, Iss.3, 2012-01, pp. : 943-948
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract